Have a personal or library account? Click to login
Impact of Oat-Based Products on Human Gastrointestinal Tract Cover

References

  1. Aaman, P., Graham, H. (1987). Analysis of total and insoluble mixed-linked β-D-glucans in barley and oats. J. Agric. Food Chem., 35 (5), 707-709.
  2. Andersson, K. (2009). Molecular Weight of Beta Glucans, Bioactivity. Doctoral dissertation, Lund University, Faculty of Medicine, Sweden. Media- tryck, Lund. 67 pp.
  3. Brand, T. S., Van der Merwe, J. P. (1996). Naked oats (Avena nuda) as a substitute for maize in diets for weaning and grower-finsher pigs. Anim. Feed Sci. Technol., 57, 139-141.10.1016/0377-8401(95)00827-6
  4. Breuer, R. I., Buto, S. K., Christ, M. L., Bean, J., Vernia, P., Paoluzi, P., Di Paolo, M. C., Caprilli, R. (1991). Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Preliminary report. Dig. Dis. Sci., 36 (2), 185-187.10.1007/BF01300754
  5. Cha, M. C., Purslow, P. P. (2014). Soluble fiber beta-glucan from oats at higher concentrations promotes hydrogen peroxide-induced cytotoxicity in small intestine epithelial cells. Advances Life Sci. Health, 1 (2), 36-46.
  6. Chan, G. C. F., Chan, W. K., Sze, D. M. Y. (2009). The effects of β-glucan on immune and cancer cells. J. Hemat. Oncol., 2, 25.10.1186/1756-8722-2-25
  7. Ciacci, C., Franceschi, F., Purchiaroni, F., Capone, P., Buccelletti, F., Iacomini, P., Ranaudo, A., Andreozzi, P., Tondi, P., Gentiloni Siveri, N., Gasbarrini, A., Gasbarrini, G. (2011). Effect of ß-glucan, inositol and digestive enzymes in GI symptoms of patients with IBS. Eur. Rev. Med. Pharmacol. Serv., 15, 637-643.
  8. Coman, M. M., Verdenelli, M. C., Cecchini, C., Silvi S., Vasile, A., Bahrim, G. E., Orpianesi, C., Cresci, A. (2013). Effect of buckwheat flour and oat bran on growth and cell viability of the probiotic strains Lactobacillus rhamnosus IMC 501®, Lactobacillus paracasei IMC 502® and their combination SYNBIO®, in synbiotic fermented milk. Int. J. Food Microbiol., 167 (2), 261-268.10.1016/j.ijfoodmicro.2013.09.015
  9. Cummings, J. H., Macfarlane, G. T. (1991). The control and consequences of bacterial fermentation in the human colon. J. Appl. Bacteriol., 70, 443-459.10.1111/j.1365-2672.1991.tb02739.x
  10. Di Sabatino, A., Morera, R., Ciccocioppo, R., Cazzola, P., Gotti, S., Tinozzi, F. P., Tinozzi, S, Corazza, G. R. (2005). Oral butyrate for mildly to moderately active Crohn’s disease. Aliment. Pharmacol. Ther., 22, 789-794.10.1111/j.1365-2036.2005.02639.x
  11. Eckburg, P. B., Bik, E. M., Berstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson. K. E., Relman, D. A. (2005). Diversity of the human intestinal microbial flora. Science, 308, 1635-1638.10.1126/science.1110591
  12. Anonoymous (1997). Food labeling: Health claims; oats and coronary heart disease; final rule. Federal Register (Food and Drug Administration, USA), 62 (15), 3583-3601.
  13. Feldman, M., Friedman, L. S., Brandt, L. J. (eds.) (2010). Sleisenger and Fordtran’s Gastrointestinal and Liver Disease-2 Volume Set. 9th edn. Saunders Elsevier, Philadelphia. 2480 pp.
  14. Freimund, S., Sauter, M., Kapelli, O., Dutler, H. (2003). A new nondegradingisolation process for 1.3-β-glucan of high purity from baker’s yeast saccharomyces cerevisae. Carbohyd. Polym., 54, 159-171.10.1016/S0144-8617(03)00162-0
  15. Galvez, J., Rodríguez-Cabezas, M. E., Zarzuelo, A. (2005). Effects of dietary fiber on inflammatory bowel disease. Mol. Nutr. Food Res., 49 (6), 601-608.10.1002/mnfr.20050001315841496
  16. Gálvez, J. (2014). Role of Th17 Cells in the Pathogenesis of IBD. Int. Schol. Res. Notices Inflamm. Article ID 928461, 14 pp. htpp:/dx.doi.org.10.1155.2014/928461 (accessed 15 June 2015).
  17. Gibson, G. R, Roberfroid, M. B. (1995). Dietary modulation of the human microbiota: Introducing the concept of prebiotics. J. Nutr., 125, 1401-1412.10.1093/jn/125.6.14017782892
  18. Guyonnet, D., Chassany, O., Ducrotte, P., Picard, C., Mouret, M., Mercier, C. H., Matuchansky, C. (2007). Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: A multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol. Ther., 26, 475-486.10.1111/j.1365-2036.2007.03362.x17635382
  19. Hampshire, J. (2004). Variation in the content of nutrients in oats and its relevance for the production of cereal products. Proceedings of the 7th International Oat Conference, Helsinki, Finland. Agrifood Res. Rep., 51, 126.
  20. Hughes, S. A, Shewry, P. R., Gibson, G. R, McCleary, Rastall, R. A. (2008). In vitro fermentation of oat and barley derived β-glucans by human faecal microbiota. FEMS (Federation of European Microbiological Societies) Microbiol. Ecol., 6 (3), 482-493.10.1111/j.1574-6941.2008.00478.x18430007
  21. Jenkins, D. J., Kendall, C. W., Popovich, D. G., Vidgen, E., Mehling, C. C., Vuksan, V., Ransom, T. P., Rao, A. V., Rosenberg-Zand, R., Tariq, N., Corey, P., Jones, P. J., Raeini, M., Story, J. A., Furumoto, E. J., Illingworth, D. R., Pappu, A. S., Connelly, P. W. (2001). Effect of a very-high-fiber vegetable, fruit, and nut diet on serum lipids and colonic function. Metabolism, 50 (4), 494-503.10.1053/meta.2001.2103711288049
  22. Johansson, L. (2006). Structural analyses of (1β3),(1_4)-_-D-glucan of oats and barley. Published doctoral dissertation. University of Helsinki, Department of Applied Chemistry and Microbiology, General Chemistry Division, Helsinki.
  23. Kajander, K., Myllyluoma, E., Rajiliã-Stojanoviã, M., Kyrönpalo, S., Rasmussen, M., Järvenpää, S., Zoetendal, E. G., de Vos, W. M., Vapaatalo, H., Korpela, R. (2008). Clinical trial: Multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol. Ther., 27 (1), 48-57.10.1111/j.1365-2036.2007.03542.x17919270
  24. Katz, S. (2007). “Mind the Gap”: An unmet need for new therapy in IBD. J. Clin. Gastroenterol., 41, 799-809.10.1097/MCG.0b013e318033d71d17881924
  25. Kedia, G., Váquez, J. A., Pandiella, S. S. (2009). In vitro fermantation of oat bran obtained by debranning with a mixed culture of human faecal bacteria. Curr. Microbiol., 4, 338-342.10.1007/s00284-008-9335-119085033
  26. Lakatos, P. L. (2006). Recent trends in the epidemiology of inflammatory bowel diseases: Up or down? World J. Gastroenterol., 12, 6102-6108.10.3748/wjg.v12.i38.6102408810117036379
  27. Macfarlane, S., Furrie, E., Cummings, J. H., Macfarlane, G. T. (2004). Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients in ulcerative colitis. Clin. Infect. Dis., 38, 1690-1699.10.1086/42082315227614
  28. Madden, J. A., Hunter, J. O. (2002).Areview of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Brit. J. Nutr., 88 Suppl 1, 67-72.10.1079/BJN200263112215182
  29. Maloy, K. J, Kullberg, M. C. (2008). Il-23 and Th17 cytokines in intestinal homeostasis. Mucosal Immunol., 1 (5), 339-349.10.1038/mi.2008.2819079198
  30. Mantzouridou, F., Karousioti, A., Kiosseoglou, V. (2013). Formulation optimisation of a potentially prebiotic low-in-oil oat-based salad dressing to improve Lactobacillus paracasei subsp.paracasei survival and physicochemical characteristics. Food Sci. Technol., 53 (2) 560-568.
  31. Mariat, D., Firmesse, O., Levenez, F., Guimarães, V. D., Sokol, H., Doré, J., Corthier, G., Furet, J. P. (2009). The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol., 9, 123. Nilsson, U., Johansson, M., 10.1186/1471-2180-9-123270227419508720
  32. Nilsson, Å., Björck, I., Nyman, M. (2008). Dietary supplementation with β-glucan enriched oat bran increases faecal concentration of carboxylic acids in healthy subjects. Eur. J. Clin. Nutr., 62, 978-984.10.1038/sj.ejcn.160281617522598
  33. Nobaek, S., Johansson, M. L., Molin. G., Ahrné, S., Jeppsson, B. (2000). Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Amer. J. Gastroenterol., 95 (5), 1231-12388.10.1111/j.1572-0241.2000.02015.x10811333
  34. Peterson, D. M, Wood, D. F. (1997). Composition and structure of high-oil oat. J. Cereal Sci., 26 (1), 121-128.10.1006/jcrs.1996.0111
  35. Polle, S. W., Bemelman, W. A. (2007). Surgery insight: Minimally invasive surgery for IBD. Nat. Clin. Pract. Gastroenterol. Hepatol., 4, 324-335.
  36. Reese, E. T., Parrish, F. W., Mandels, M. (1962). β-D-1,6-glucanases in fungi. Can. J. Microbiol., 8 (3), 327-334.10.1139/m62-04514491003
  37. Rothfuss, K. S., Stange, E. F., Herrlinger, K. R. (2006). Extraintestinal manifestations and complications in inflammatory bowel disease. World J. Gastroenterol., 12 (30), 4819-4831.10.3748/wjg.v12.i30.4819408761516937463
  38. Sangwan, S., Singh, S., Tomar, S. K. (2014). Nutritional and functional properties of oats: An update. J. Innovative Biol., 1 (1), 3-14.
  39. Scheemann, B. O. (1987). Dietary fiber and gastrointestinal function. Nutr. Rev., 45 (5), 129-132.
  40. Sekirov, I., Russell, S. L., Antunes, L. C., Finlay, B. B. (2010). Gut microbiota in health and disease. Physiol. Rev., 90 (3), 859-904.10.1152/physrev.00045.200920664075
  41. Smith, E. A., Macfarlane, G. T. (1996). Enumeration of human colonic bacteria producing phenolic and indolic compounds: Effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J. Appl. Bacteriol., 81, 288-302.10.1111/j.1365-2672.1996.tb04331.x8810056
  42. Steinhart, A. H., Hiruki, T., Brzezinski, A, Baker, J. P. (1996). Treatment of left-sided ulcerative colitis with butyrate enemasa controlled trial. Aliment Pharmacol. Ther., 10 (5), 729-736.10.1046/j.1365-2036.1996.d01-509.x8899080
  43. Surlin, V., Copaescu, C., Saftoiu, A. (2012). An update to surgical management of inflammatory bowel diseases. DOI: http:/dx.doi.org/10.5772/53057. http://cdn.intechopen.com/pdfs-wm/41223.pdf (accessed 12 April 2015).
  44. Tedelind, S., Westberg, F., Kjerrulf, M., Vidal, A. (2007). Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: A study with relevance to inflammatory bowel disease. World J. Gastroenterol., 13, 2826-2832.10.3748/wjg.v13.i20.2826439563417569118
  45. Thornton, J. R. (1981). High colonic pH promotes colorectal cancer. Lancet, 1, 1699-1728.10.1016/S0140-6736(81)92244-3
  46. Wang, Q., Ellis, P. R. (2014). Oat β-glucan: Physico-chemical characteristics in relation to its blood-glucose and cholesterol-lowering properties. Brit. J. Nutr., 112 Suppl 2, S4-S13.10.1017/S000711451400225625267243
  47. Whitehead, A., Beck, E. J., Tosh, S. M, Wolever, T. M. S. (2014). Cholesterol- lowering effects of oat β-glucan: A meta-analysis of randomized controlled trials. Amer. J. Clin. Nutr., 100 (6), 1413-1421.10.3945/ajcn.114.086108539476925411276
  48. Wood, P. J., Weisz, J., Blackwell, B. A. (1994). Structural studies of (1β3) (1β4)- β -D-glucans by 13C-nuclear magnetic resonance spectroscopy and by rapid analysis of cellulose-like regions using high-performance anion- exchangechromatography of oligosaccharides released by lichenase. Cereal Chem., 35, 301-307.
  49. Wood, P. J., Weisz, J., Mahn, W. (1991). Molecular characterization of cereal, β-glucans. II. size-exclusion chromatography for comparison of molecular weight. Cereal Chem., 68 (5), 530-536.
  50. Wolever, T. M., Tosh, S. M., Gibbs, A. L., Brand-Miller, J., Duncan, A. M., Hart, V., Lamarche, B., Thomson, B. A., Duss, R., Wood, P. J. (2010). Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: A randomized clinical trial. Amer. J. Clin. Nutr., 92 (4), 723-32.10.3945/ajcn.2010.2917420660224
  51. Zoetendal, E. G., Collier, C. T., Koike, S., Mackie, R. I, Gaskins, H. R. (2004). Molecular ecological analysis of the gastrointestinal microbiota: A review. J. Nutr., 134, 465-472.10.1093/jn/134.2.46514747690
  52. Wolever, T. M., Spadafora, P., Eshuis, H. (1991). Interaction between colonic propionate and acetate in humans. Amer. J. Clin. Nutr., 53 (3), 681-687. 10.1093/ajcn/53.3.6812000822
DOI: https://doi.org/10.1515/prolas-2015-0021 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 145 - 151
Submitted on: Apr 14, 2015
Published on: Oct 6, 2015
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2015 Aiga Staka, Edgars Bodnieks, Aldis Puķītis, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.